Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09) Among 222 patients randomly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results